Mutagenicity of the total organic extract was always higher than those of the corresponding pure mycotoxins tested alone or in reconstituted mixtures with equivalent concentrations. Since AFB~2~ and AFM~1~ modulate negatively the mutagenicity of AFB~1~ when mixed in binary or tertiary mixtures, thus additional compounds contributed to the mutagenicity of the total organic extract.

1. Introduction {#sec1-toxins-12-00458}
===============

We have previously demonstrated in an agricultural environment (Normandy, France), that oilseed cakes and maize silage used for cattle food could be contaminated with Aspergilli, especially *A. flavus, A. parasiticus* and *A. fumigatus*, even in temperate/mild climate \[[@B1-toxins-12-00458],[@B2-toxins-12-00458]\]. Moreover, bioaerosols resulting from breeding activities were also contaminated by airborne molds \[[@B3-toxins-12-00458],[@B4-toxins-12-00458]\]. Among them, some species belonging to *Aspergillus* genus are well-known as potential producers of various mycotoxins such as aflatoxins, gliotoxin, verruculogen or fumagillin. The toxic effects of these purified mycotoxins (carcinogenicity, cytotoxicity, neurotoxicity, immunosuppressive effects) have been widely described so far \[[@B5-toxins-12-00458],[@B6-toxins-12-00458],[@B7-toxins-12-00458],[@B8-toxins-12-00458],[@B9-toxins-12-00458]\]. Thus, aflatoxin B~1~ (AFB~1~), produced by the *Aspergilli flavus* group, had well known mutagenic and genotoxic properties and is classified in group 1 by the International Agency for Research on Cancer (IARC), due to its carcinogenic potential \[[@B10-toxins-12-00458]\]. Gliotoxin, produced by *A. fumigatus*, was found to be genotoxic using the bacterial repair assay (*E. coli* WP2 strain vs. its repair deficient derivative CM871) and the comet assay on RAW264.7 macrophages (cell line issued from mice). In contrast, no significant effect was reported in the *Salmonella* test nor in the SOS-chromotest or in Chinese hamster ovarian (CHO) cells for the induction of sister chromatide exchanges (SCE) \[[@B11-toxins-12-00458]\]. Stanimirovic et al. \[[@B12-toxins-12-00458]\] and Stevanovic et al. \[[@B13-toxins-12-00458]\] suggested that fumagillin had clastogenic and cytotoxic potentials (inducing micronuclei (MN) and chromosomal aberrations (CA)) in vitro (human lymphocytes) and in vivo (mice BALB/c). Verruculogen, also produced by *A. fumigatus*, was reported as mutagenic towards various strains in the *Salmonella*/mammalian-microsome assay (Ames test) \[[@B14-toxins-12-00458]\]. In contrast, little is known about the mutagenic properties of the mixtures of secondary metabolites naturally produced by environmental fungal isolates. Bjeldanes et al. \[[@B15-toxins-12-00458]\] reported that chloroformic extracts obtained from cultures of *A. flavus* and *A. parasiticus* displayed a mutagenic behaviour in TA100 in the presence of S9mix (Ames test).

In this context, the aim of the present study was to characterize the mutagenic patterns of *A. flavus, A. parasiticus* and *A. fumigatus* extracts, prepared from cultures of fungal strains previously isolated from the occupational agricultural environment. Comparisons between mycotoxin-producer and non-producer isolates were performed using the Ames test on strains TA98, TA100 and TA102, without and with S9mix addition. These data were then compared with the mutagenicity of the corresponding pure mycotoxin standards tested alone or in reconstituted binary and ternary mixtures with equivalent concentrations, in order to examine the potential interactions between these molecules and the involvement of other natural metabolites.

2. Results {#sec2-toxins-12-00458}
==========

2.1. Mycotoxin Production {#sec2dot1-toxins-12-00458}
-------------------------

Toxigenic *A. flavus* and *A. parasiticus* strains both synthesize AFB~1~ and, to a lesser extent, AFB~2~, whereas AFM~1~ is naturally produced only by the toxigenic *A. flavus* ([Table 1](#toxins-12-00458-t001){ref-type="table"}). Mycotoxin production is 20- to 40-fold higher for *A. flavus* as compared to *A. parasiticus*. None of these mycotoxins were detected for the so-called "non toxigenic" corresponding strains. The two strains of *A. fumigatus* were toxigenic, producing roughly comparable fumagillin and verruculogen levels, but they differ with regard to their gliotoxin synthesis potential ([Table 1](#toxins-12-00458-t001){ref-type="table"}).

2.2. Mutagenicity of Fungal Extracts {#sec2dot2-toxins-12-00458}
------------------------------------

Mutagenicity was evaluated using the Ames test in three *Salmonella* tester strains with and without exogenous metabolic activation system (S9mix). TA98 is sensitive to chemicals acting through frameshift mechanism, whereas TA100 and TA102 are sensitive to chemicals acting through base pair substitutions mechanism.

### 2.2.1. *Aspergillus flavus* Extracts {#sec2dot2dot1-toxins-12-00458}

The mutagenic potential of the (Flav^+^) extract is displayed in [Table 2](#toxins-12-00458-t002){ref-type="table"} (direct mutagenicity) and [Table 3](#toxins-12-00458-t003){ref-type="table"} (upon S9mix addition). Significant responses were observed in the three *Salmonella* tester strains, in absence as well as in presence of S9mix, except for strain TA102 for which no direct mutagenicity was observed.

Moreover, significant mutagenicities were systematically coupled with a clear dose--response relationship, and were dramatically increased in the presence of S9mix ([Table 3](#toxins-12-00458-t003){ref-type="table"}). In contrast, no mutagenic response was observed from the (Flav−) extract.

### 2.2.2. *Aspergillus parasiticus* Extract {#sec2dot2dot2-toxins-12-00458}

No mutagenic activity was detected for the (Para^−^) extract ([Table 4](#toxins-12-00458-t004){ref-type="table"} and [Table 5](#toxins-12-00458-t005){ref-type="table"}). In contrast, upon S9mix addition, the (Para^+^) extract was mutagenic in the three *Salmonella* tester strains ([Table 5](#toxins-12-00458-t005){ref-type="table"}), with a dose-response relationship. Without S9mix ([Table 6](#toxins-12-00458-t006){ref-type="table"}), a dose-dependent mutagenic response was obtained in TA98 only.

### 2.2.3. *Aspergillus fumigatus* Extract {#sec2dot2dot3-toxins-12-00458}

There was no mutagenic activity observable in *Salmonella* tester strains TA98 and TA100 ([Table 6](#toxins-12-00458-t006){ref-type="table"} and [Table 7](#toxins-12-00458-t007){ref-type="table"}). In TA102, both extracts presented a low mutagenicity only upon addition of S9mix ([Table 7](#toxins-12-00458-t007){ref-type="table"}).

2.3. Mutagenicity of the Mycotoxin Mixtures {#sec2dot3-toxins-12-00458}
-------------------------------------------

Reconstituted mixtures were prepared from pure mycotoxins with concentrations corresponding to those measured in extracts. These binary and ternary mixtures were then tested for their mutagenic potential.

Compared to their corresponding extracts (Flav^+^) and (Para^+^) ([Table 2](#toxins-12-00458-t002){ref-type="table"}, [Table 3](#toxins-12-00458-t003){ref-type="table"}, [Table 4](#toxins-12-00458-t004){ref-type="table"} and [Table 5](#toxins-12-00458-t005){ref-type="table"}), the respective mixtures prepared from pure aflatoxins were systematically and significantly less mutagenic (2 to 10-fold; p \< 10^−4^) towards the three *Salmonella* tester strains. In the range of concentrations tested, the binary mixture (AFB~2~ + AFM~1~) was not mutagenic ([Table 2](#toxins-12-00458-t002){ref-type="table"} and [Table 3](#toxins-12-00458-t003){ref-type="table"}), nor were the mixtures including (fumagillin + verruculogen ± gliotoxin), in the three *Salmonella* strains used ([Table 6](#toxins-12-00458-t006){ref-type="table"} and [Table 7](#toxins-12-00458-t007){ref-type="table"}).

2.4. Mutagenicity of Pure Mycotoxins {#sec2dot4-toxins-12-00458}
------------------------------------

Mutagenic activities of the 6 mycotoxins detected in the different extracts ([Table 1](#toxins-12-00458-t001){ref-type="table"}) were also evaluated from pure standard solutions ([Table 8](#toxins-12-00458-t008){ref-type="table"}). In a range of concentrations equivalent (or even wider) to those tested with the whole extracts, AFB~1~ was the only one displaying a significant mutagenicity in TA98 and TA100, both without and with S9mix. In contrast, no mutagenic response was observed in TA102.

3. Discussion {#sec3-toxins-12-00458}
=============

Various Aspergilli species were isolated from our previous studies conducted in an agricultural environment. They differed considering both their ability to synthesize mycotoxins and the nature of these mycotoxins ([Table 1](#toxins-12-00458-t001){ref-type="table"}). They originated from contaminated oilseed cakes or from bioaerosols sampled in dairy cattle sheds or during cattle feed distribution. Thus, spores and mycelium fragments of these Aspergilli species could be ingested by livestock and also inhaled by farmers during their daily work. In order to evaluate the potential hazard associated with occupational exposure to these fungal strains, we measured the mutagenic potential of total extracts obtained from MEA cultures. For this purpose, *Salmonella typhimurium* TA98, TA100 and TA102 tester strains were used (Ames test) without and with the exogenous metabolic fraction S9mix. The mutagenicity of the pure mycotoxins at the same concentrations as in the extracts was evaluated and compared in order to investigate the presence of additional mutagenic compounds in these extracts. It is noteworthy that, in the range of concentrations studied, corresponding to native production levels, AFB~1~ was the sole mycotoxin displaying a significant mutagenicity when tested alone. Thus, extracts mutagenicity was discussed in comparison with that of an equivalent pure AFB~1~ concentration ([Table 9](#toxins-12-00458-t009){ref-type="table"}).

AFB~1~ and AFB~2~ were found in the (Flav^+^) extract and, to a lesser extent, in the (Para^+^). It must be stressed that AFM~1~, which is mainly considered as a liver-hydroxylated metabolite of AFB~1~, was detected in the (Flav^+^) extract. This direct production of AFM~1~ by *A. flavus* was also recently reported by Uka et al. \[[@B16-toxins-12-00458]\], but does not appear to have been commonly described.

A significant direct mutagenicity was observed in TA98 for (Flav^+^) and (Para^+^) extracts as well as for pure AFB~1~. Previously, Loarca-Piña et al. \[[@B17-toxins-12-00458]\] reported a direct mutagenicity for AFB~1~, using the microsuspension assay. Compared with our study, they reported comparable mutagenic potencies for TA100 (0.5 vs. 0.54 revertants/ng) but somewhat higher for TA98 (0.4 *vs* 0.18 revertants/ng). In the present work, the responses observed for (Flav^+^) and even more for (Para^+^) extracts were largely enhanced (2- to 8-fold) compared with the same dose of pure AFB~1~ ([Table 9](#toxins-12-00458-t009){ref-type="table"}). Similarly, a higher direct mutagenicity was obtained in TA100 only for the (Flav^+^) extract, compared to pure AFB~1~ ([Table 9](#toxins-12-00458-t009){ref-type="table"}).

Upon addition of S9mix, the mutagenic activities dramatically increased (50- to 100-fold) in both strains TA100 and TA98 ([Table 9](#toxins-12-00458-t009){ref-type="table"}). Under these conditions, (Flav^+^) and (Para^+^) extracts are 2 to 4-fold more mutagenic than AFB~1~ alone. The (Para^+^) extract was a more potent mutagen than (Flav^+^) in TA98 (71.6 vs. 47.3 revertants/ng AFB~1~), whereas in TA100, (Flav^+^) appeared the most mutagenic (172 vs. 99 revertants/ng AFB~1~). Additionally, in TA102, comparable significant responses were obtained for (Flav^+^) and (Para^+^) extract (5.5 and 4.4 revertants/ng AFB~1~ respectively), but not for pure AFB~1~.

Thus, these patterns indicate that AFB~1~ is only one of the direct- and indirect-mutagenic compounds present in the total extracts. Moreover, the absence of mutagenicity for (Flav^-^) and (Para^-^) extracts could indicate that additional metabolites are closely related to the AFB~1~ synthesis pathway. Recently, Uka et al. \[[@B16-toxins-12-00458]\] highlighted the particularly high intra-species diversity of *A. flavus* and reported the large variety of secondary metabolites that can be produced. Using a metabolomic approach on 55 isolates of *A. flavus*, they identified more than 50 metabolites even if only half of the 55 strains were considered as aflatoxin producers. Beside aflatoxins (AFB~1~, AFB~2~ and possibly AFB~2a~, AFM~1~, AFG~1~, AFG~2~) and their known precursors (sterigmatocystin and derived compounds), biocoumarins (aflavarin and derived compounds) with anti-insectan activity, isocoumarines (asperentin and derived compounds), anthraquinones (asparasone and derived compounds), non-ribosomal peptides (aspergillic acid and derived compounds) with antibiotic activity and indol-diterpenoids (aflavinines and aflatrem) with tremorgenic potential were identified. However, among these metabolites, only sterigmatocystin was reported as mutagenic in Ames test, both in TA100 (400 revertants/0.1 µg with S9mix and 150 revertants/0.1 µg without S9mix) and in TA98 (190 revertants/0.1 µg with S9mix and 40 revertants/0.1 µg without S9mix) \[[@B18-toxins-12-00458]\].

Aflatoxicol displayed also a mutagenic potential in the presence of mammalian microsomes \[[@B19-toxins-12-00458]\]. The production of aflatoxicol by *A. flavus*, as well as its possible interconversion with AFB~1~ have been previously reported by Nakazato et al. \[[@B20-toxins-12-00458],[@B21-toxins-12-00458]\].

Moreover, the mutagenic activities measured from (Flav^+^) and (Para^+^) extracts were always significantly higher than those obtained with the corresponding reconstituted mixtures of pure mycotoxins. These observations argue again in favour of additional components extracted from fungal cultures, and contributing to the overall mutagenic response.

The potential interactions between identified mycotoxins were also considered. Thus, the mutagenicity of reconstituted mixtures was compared to that of pure mycotoxins tested individually. Despite the fact that AFB~2~ and AFM~1~ were not mutagenic per se in our conditions, their association with AFB~1~ was systematically linked to a significantly decreased mutagenicity of the corresponding binary or ternary mixtures, indicating a potential negative interaction between these structurally close molecules. A competitive mechanism during the S9 metabolic activation step could be evoked. Since AFB~2~ and AFM~1~ are structurally close to AFB~1~, they could also be substrate for cytochrome P450 enzymes (CYP), leading to a competition between these mycotoxins for the binding step to enzyme. Interaction could also occur later, once the 8,9-epoxide metabolites formed. Indeed, a transient intercalation step precedes the formation of DNA adducts \[[@B22-toxins-12-00458],[@B23-toxins-12-00458]\]. This intercalation in the 5′ side of the guanine target facilitates further adduct formation by favourably positioning the epoxide for subsequent nucleophilic attack by the guanine N7 \[[@B23-toxins-12-00458],[@B24-toxins-12-00458]\]. The metabolites derived from AFB~2~ and AFM~1~ could potentially interact with this transient intercalation state, resulting in a decreased mutagenicity of AFB~1~ tested in binary or tertiary mixtures. But, since the negative modulation on mutagenicity was also observed without S9mix, additional but as yet unidentified interaction targets must be involved, independently of the metabolic activation step.

Indeed, at least three mechanisms are presumably involved in the mutagenic responses of these aflatoxins: (a)the most powerful and classically described towards TA98 and TA100 upon addition of S9mix involves CYPs in the formation of reactive intermediates such as AFB~1~-*exo*-8,9-epoxide, and the subsequent binding to the N7 guanine in DNA to form AFB~1~-N7-Gua adducts then, subsequently, the imidazole ring-opened form AFB~1~-FapyGua, this latter being more mutagenic than the former \[[@B25-toxins-12-00458],[@B26-toxins-12-00458]\];(b)a direct mutagenicity towards these two strains, observed for higher doses of mycotoxins, that did not involve any exogenously activated intermediates;(c)and a mechanism detected in TA102 for the three extracts only upon addition of S9mix, could potentially be subsequent to oxidative damage, since TA102 is responsive to this kind of damage \[[@B27-toxins-12-00458]\].

It has been reported that exposure to AFB~1~ could led to oxidative damage, either in vitro \[[@B28-toxins-12-00458],[@B29-toxins-12-00458],[@B30-toxins-12-00458],[@B31-toxins-12-00458]\] or in vivo \[[@B9-toxins-12-00458],[@B31-toxins-12-00458],[@B32-toxins-12-00458],[@B33-toxins-12-00458]\]. Hence, Guindon et al. \[[@B34-toxins-12-00458]\] reported an elevation of 8-hydroxy-2′-deoxyguanosine (8-OH-dG) adducts in mice lung, and more recently, Coskun et al. \[[@B35-toxins-12-00458]\] described an optimized protocol to detect (5′R)- and (5′S)-8,5′-cyclo-2′-deoxyadenosines in mice liver. Thus, it is now currently recognized that this mechanism contributes to the overall toxicity and genotoxicity of this mycotoxin. However, pure AFB~1~ was never reported mutagenic in TA102, thus the mutagenicty observed with extracts should be attributed to other secondary metabolites.

Verruculogen and fumagillin were produced in the same order of magnitude by the two strains of *A. fumigatus* that differed regarding their capacity to synthesize gliotoxin. These extracts did not display any direct mutagenicity, but borderline responses were obtained for both extracts in TA102 upon addition of S9mix. When purified standards were tested in parallel, none of them were found mutagenic in the range of concentrations corresponding to the native production of *A. fumigatus* strains. These data are in accordance with previous results for gliotoxin \[[@B11-toxins-12-00458],[@B36-toxins-12-00458]\]. Even if verruculogen was reported as mutagenic in TA98 and TA100 \[[@B14-toxins-12-00458]\], the tested doses were about four orders of magnitude higher than those tested in the present study. Fumagillin was reported clastogenic, inducing AC and MN \[[@B12-toxins-12-00458]\], but no data were found regarding the mutagenic potency in the *Salmonella* assay. Thus, as previously suggested for (Flav^+^) and (Para^+^) extracts, identified mycotoxins or their interactions cannot explain the weak mutagenicity observed in TA102 with S9mix, so additional mutagenic compounds might be produced by *A. fumigatus*.

To date, interactions between aflatoxins tested in mixtures have not been extensively investigated. Using the Ames test, only Said et al. \[[@B37-toxins-12-00458]\] described a non-additive effect of AFB~1~ and N-acetylaminofluorene. Interaction mechanisms were more often studied towards various cell culture models or even in vivo. Hence, recently, Li et al. \[[@B31-toxins-12-00458]\] reported a stronger renal toxicity of AFB~1~ and AFM~1~ when mixed, involving a pro-oxidant mechanism both in vitro (HEK 293 cells) and in vivo (CD-1 mice). Actually, AFB~1~ was most of the time tested in mixture with structurally distinct mycotoxins, such as fumonisin B~1~ (FB~1~) and ochratoxin (OTA). Antagonistic effect of (AFB~1~ + FB~1~) mixture was shown on HepG2 cells cytotoxicity whereas in contrast, synergistic mechanism was obtained on BEAS-2B cell as well as on F-344 rats mortality \[[@B38-toxins-12-00458]\]. Theumer et al. \[[@B39-toxins-12-00458]\] observed a more pronounced apoptosis in rat livers when FB~1~ and AFB~1~ were mixed, together with enhanced impairments in sphingolipid metabolism. They also reported significant DNA damage in spleen mononuclear cells from rats fed with this mixture \[[@B33-toxins-12-00458]\]. On monkey kidney Vero cells, additive interactions were observed for (AFB~1~ + OTA) mix: cell viability was reduced and DNA damage was increased \[[@B40-toxins-12-00458]\]. But in HCT-8 intestinal cancer cells, antagonistic effects were observed on various AFB~1~-induced biomarkers (DNA adducts formation, p53 induction or Mdm2 expression) \[[@B41-toxins-12-00458]\]. Thus, no general rule could be inferred from these data, due to the variety of biological models, protocols, mycotoxin associations and mathematical models used to describe mycotoxin interactions. But the negative interaction observed in the present study for the reconstituted mixtures involving aflatoxins was in accordance with some previous experiments conducted on cell cultures.

4. Conclusions {#sec4-toxins-12-00458}
==============

After isolation of various fungal strains, we evaluated their toxigenic and mutagenic properties. We thus demonstrated that some of these isolates were able to produce mycotoxins in vitro which could result in a potential hazard for farmers as well as for livestock.

We also showed that, besides identified mycotoxins, additional secondary metabolites should contribute to the global mutagenic responses evaluated with the Ames test.

Among the identified aflatoxins, AFB~1~ was the sole mutagenic found when tested from pure standards in a range of doses corresponding to those measured in extracts. However, its association with AFB~2~ and AFM~1~ led to a decreased mutagenicity, indicating that AFB~2~ and/or AFM~1~ negatively modulate the toxicity of the corresponding mixture. AFB~1~ is rarely produced alone from fungi, and genotoxicity of combined mycotoxins is hard to predict. Thus, mutagenic activity assessment of the "natural" complex mixtures appears more informative and relevant than those of some isolated mycotoxins or reconstituted mixtures for hazard assessment.

Finally, the panel of *Salmonella* tester strains used indicates that various mechanisms were involved in the mutagenic responses. Besides the well documented formation of AFB~1~ 8,9-epoxide upon S9mix addition, and the subsequent formation of DNA adducts, a direct mutagenicity was also observed for higher doses in TA98 and TA100 which, therefore, did not involve exogenous activation. An additional contribution through oxidative damage was also detected upon addition of S9mix.

5. Materials and Methods {#sec5-toxins-12-00458}
========================

5.1. Strain Collection {#sec5dot1-toxins-12-00458}
----------------------

The non toxigenic *A. flavus* strain was isolated from a bioaerosol sampled in a dairy cattle shed in Normandy \[[@B4-toxins-12-00458]\]. The toxigenic *A. flavus* strain was purified from contaminated oilseed cakes, as well as the non toxigenic *A. parasiticus* strain \[[@B2-toxins-12-00458]\]. The toxigenic *A. parasiticus* was obtained from a bioaerosol collected during the distribution of cattle feed \[[@B3-toxins-12-00458]\].

The gliotoxin producer strain of *A. fumigatus* was isolated from a dairy cattle shed bioaerosol \[[@B4-toxins-12-00458]\] whereas the non-producer strain was obtained from a contaminated oilseed cake sample \[[@B2-toxins-12-00458]\].

All isolates were preserved on malt extract agar (MEA) in the laboratory mycological bank (stored at 4 °C).

5.2. Toxigenic Ability of Fungal Isolates {#sec5dot2-toxins-12-00458}
-----------------------------------------

Each isolate was tested in triplicate for its ability to produce mycotoxins in vitro. Each strain was cultivated on MEA. The plates were incubated at 25 °C for two weeks and then three agar plugs measuring 8 mm in diameter were removed from the central area of the colony (including conidia and mycelium), pooled, weighted and transferred to 5-mL glass vials as previously described by Garon et al. \[[@B42-toxins-12-00458]\]. Mycotoxins were extracted by 2 mL of ethyl acetate acidified with 1% acetic acid as recommended by Samson et al. \[[@B43-toxins-12-00458]\]. After 15 min of centrifugation at 1500 rpm, each extract was evaporated to dryness under a stream of nitrogen. The residue was dissolved in 0.5 mL of an acetonitrile--water mixture (10:90 v/v) and filtered through Millex HV 0.45 µm before their injection into the high-performance liquid chromatography coupled with mass spectrometry (HPLC--MS/MS). Aflatoxins were then quantified by HPLC--MS/MS in multiple reaction monitoring (MRM) according to the method described by Pottier et al. \[[@B44-toxins-12-00458]\]. Mycotoxins were quantified by HPLC--MS/MS in MRM. Liquid chromatography was performed using an Agilent Technologies 1200 HPLC system coupled to a triple quadrupole spectrometer (6460 series, Agilent Technologies, Santa Clara, CA, USA) equipped with an electrospray interface, operated in the positive and negative modes. The MassHunter B.02.00 software was used for data processing.

The analytes were chromatographed according to 2 chromatographic methods.

Eleven mycotoxins (aflatoxins B~1~, B~2~, G~1~, G~2~, M~1~, diacetoxyscirpenol, gliotoxin, mycophenolic acid, neosolaniol, ochratoxin A, T-2 toxin) were separated (Method 1) onto Zorbax SB, Rapid Resolution HT-C18 column (1.7 µm, 50 × 2 mm; Agilent Technologies) at 60 °C. Fumonisin B~1~-13C34 was used as internal standard. The injection volume of the samples on the analytical column was 10 µL. The mobile phase consisted of a variable mixture of acetonitrile (solvent A) and water added with formic acid 1% (solvent B) at a flow rate of 0.4 mL/min. A linear gradient was run starting with 10% to 100% solvent A over 10 min and staying at 100% over 1 min.

The mass spectrometer was operated in positive mode using dynamic MRM. The nebulizer gas and desolvatation gas were respectively nitrogen heated at 300 °C at 10 L/min and 400 °C at 12 L/min.

Nine mycotoxins (alternariol, deoxynivalenol, deepoxydeoxynivalenol, 3-acetyldeoxynivalenol, 15-acetyldeoxynivalenol, fusarenon X, HT-2 toxin, verrucarol, zearalenone) were separated (Method 2) onto a Zorbax Eclipse Plus, Rapid Resolution HD-C18 column (1.7 µm, 50 × 2 mm; Agilent Technologies) at 60 °C. Deoxynivalenol-13C15 was used as internal standard. The injection volume of the samples on the analytical column was 20 µL. The mobile phase consisted of a variable mixture of methanol (solvent A) and water (solvent B) at a flow rate of 0.4 mL/min. A linear gradient was run, starting with 10% to 100% solvent A over 10 min and staying at 100% over 1 min.

The mass spectrometer was operated in both negative and positive modes using MRM. Three retention windows were defined according to the retention time and the optimized ESI mode. The nebulizer gas and desolvatation gas were nitrogen heated at 250 °C at 10 L/min (excepted for the third retention window, at 12 L/min) and 400 °C at 12 L/min respectively.

Other common parameters used for the mass spectrometer were as follow: capillary voltage, 4.0 kV; pressure of nebulization, 45 psi; nozzle voltage, 300 V.

The most abundant product ion after collision-induced fragmentation was used for quantitative purposes, and the second product ion for confirmation. The linearity was done by spiking increasing concentrations (triplicate) of the mycotoxin standards (0.1 to 50 µg/L). The quantification and detection limits (QL and DL) were determined by spiked samples based on signal to noise ratio of 10:1 for quantification, and 3:1 for detection limit.

Using this multimycotoxin protocol, 6 mycotoxins were found from fungal cultures, namely aflatoxin B~1~, B~2~, and M~1~, fumagillin, gliotoxin and verruculogen. The quantification limits were 0.5 µg/L for AFB~1~, AFB~2~, AFM~1~, fumagillin and verruculogen, and 2.5 µg/L for gliotoxin.

5.3. Mutagenicity {#sec5dot3-toxins-12-00458}
-----------------

### 5.3.1. Extract Preparation {#sec5dot3dot1-toxins-12-00458}

For the mutagenic potential evaluation, the dry residues obtained above were dissolved in 550 µL DiMethylSulfOxyde (DMSO) and filtered through Millex PTFE HV 0.45 μm (i.e; resistant Teflon).

These extracts were abbreviated as follow: (Flav^+/−^) = extracts obtained from *A. flavus* isolates (^+/−^ for toxigenic/not toxigenic strain), (Para^+/−^) = extracts obtained from *A. parasiticus* isolates and (Fum~Glio+/−~) = extracts obtained from *A. fumigatus* (both strains synthesized fumagillin and verruculogen, but ~Glio+/−~ distinguish strains that are able or not to synthesize gliotoxin).

### 5.3.2. Mixture of Mycotoxins {#sec5dot3dot2-toxins-12-00458}

Standard mycotoxins aflatoxin B~1~, B~2~, M~1~ (certified grade, Cluzeau Info Labo, Ste Foy la Grande, France); fumagillin, gliotoxin, and verruculogen (Sigma-Aldrich (St. Louis, MO, USA) were tested alone and mixed at identical concentrations to those found in extracts.

### 5.3.3. Ames Test Procedure {#sec5dot3dot3-toxins-12-00458}

Overnight cultures (12 h at 37 °C with continuous shaking) of *Salmonella typhimurium* tester strains TA98, TA100 and TA102 (Trinova Biochem, Giessen, Germany) were obtained by addition of 30µL of frozen culture in 10 mL of Oxoid nutrient broth N°2 solution (0.25 g/10 mL distillated water). The Ames test included a preincubation step as previously described \[[@B44-toxins-12-00458]\]. Briefly, 10 µl of samples (extracts, pure mycotoxins or their mix dissolved in DMSO) were mixed with 100 µl of bacterial overnight culture and either 100 µL of S9mix (prepared with 5% S9) or 100 µL phosphate buffer (for conditions without S9mix). The S9 fraction was obtained from livers of Aroclor 1254-induced Sprague--Dawley male rats (Moltox, Boone, NC, USA). After 60 min shaking (185 rpm at 37 °C), 2 mL of molten agar (agar 0.6% and NaCl 0.5% *w*/*v* in distillated water) supplemented with histidine- and biotin traces (final concentration 0.5 g/L and 0.012 g/L for histidine and biotin respectively) were added to the tubes and quickly poured onto minimal glucose plates (containing agar, glucose and mineral salts; for detailed composition, see Maron and Ames \[[@B45-toxins-12-00458]\]). After 48 h incubation at 37 °C, the number of revertants was automatically counted (Noesis software, Saint Aubin, France). For each sample, three concentrations were tested, in triplicate. Results were repeated in two to four independent experiments. Previous studies led us to consider a significant mutagenicity when the ratio (Induced revertants/Spontaneous revertants) was \>2 for TA98, ratio \> 1.6 for TA100 and ratio \> 1.3 for TA102, together with a dose-effect relationship \[[@B46-toxins-12-00458]\]. Toxicity was evaluated in parallel by the microscopic observation of the background lawn density.

Strain-specific positive controls were used for each experiment: 2-nitrofluorene 2.5 μg/plate (TA98 wo S9mix: 886 revertants ± 161), 2-aminofluorene 0.5 µg/plate (TA98 with S9mix: 704 revertants ± 87), sodium azide 1.5 μg/plate (TA100 wo S9mix: 602 revertants ± 91) and ter-butylhydroperoxide 2 µmol/plate (TA102 wo S9Mix: 1377 revertants ± 148).

5.4. Statistical Analysis {#sec5dot4-toxins-12-00458}
-------------------------

An analysis of covariance (ANCOVA) was performed with all significant mutagenic data.

Three kinds of sample were tested, namely fungal extracts, mycotoxin mix and pure mycotoxins. A *p* value \< 0.05 was considered significant. When the difference between these samples was significant, an additional comparison by Student's test using a Bonferroni adjustment was performed.
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toxins-12-00458-t001_Table 1

###### 

Mycotoxigenicity of the extracts prepared from various *Aspergillus* strains.

  Extracts        Mycotoxins (µg/g Plug)             
  --------------- ------------------------ --------- ---------
  (Flav +)        12.14                    0.23      0.20
  (Flav −)        \<QL                     \<QL      \<QL
  (Para +)        0.30                     0.006     \<QL
  (Para −)        \<QL                     \<QL      \<QL
                  **GLIO**                 **VER**   **FUM**
  (Fumi~Glio+~)   11.6                     0.04      0.23
  (Fumi~Glio−~)   \<QL                     0.07      0.13

AFB~1~: aflatoxin B~1~, AFB~2~: aflatoxin B~2~, AFM~1~: aflatoxin M~1,~ GLIO: gliotoxin, VER: verruculogen, FUM: fumagillin; +: mycotoxigenic strain; **−**: non mycotoxigenic strain; ~Glio+/−~: strain producing/not producing gliotoxin; \<QL: below to the limit of quantification (2.5 ng/g for gliotoxin and 0.5 ng/g for other mycotoxins).

toxins-12-00458-t002_Table 2

###### 

Comparative mutagenicity of *Aspergillus flavus* (Flav^+/−^) extracts versus equivalent mix of mycotoxins, evaluated in *Salmonella* tester strains TA98, TA100 and TA102 without (−S9) metabolic activation.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Extract Type   Mycotoxins (µg/Plate)   Mutagenicity (−S9 mix) (Rev/Plate ^a^)                                                                                            
  -------------- ----------------------- ---------------------------------------- -------------- ---------------- -------------- -------------- ------------- ------------ ----
  **(Flav−)**    \<QL                    \<QL                                     \<QL           **TA98--S9**\    17 ± 4         \-             \-            \-           
                                                                                                 SRN = 26 ± 10                                                             

  (Flav+)        0.7500                  0.0140                                   0.0130         **362 ± 25**     **73 ± 7**     **61 ± 7**     12 ± 5        **76 ± 9**   

  0.3000         0.0056                  0.0052                                   **106 ± 6**    **45 ± 6**       **45 ± 5**     16 ± 9         **48 ± 10**                

  0.1500         0.0028                  0.0026                                   **41 ± 8**     33 ± 7           **42 ± 4**     18 ± 12        **41 ± 15**                

  (Flav−)        \<QL                    \<QL                                     \<QL           **TA100--S9**\   105 ± 12       \-             \-            \-           \-
                                                                                                 SRN = 146 ± 32                                                            

  (Flav+)        0.5000                  0.0093                                   0.0087         **1031 ± 178**   **240 ± 33**   **231 ± 56**   127 ± 14      184 ± 23     

  0.3000         0.0056                  0.0052                                   **685 ± 28**   **222 ± 21**     181 ± 49       144 ± 13       205 ± 39                   

  0.1500         0.0028                  0.0026                                   **344 ± 35**   190 ± 31         154 ± 29       151 ± 23       140 ± 23                   

  (Flav−)        \<QL                    \<QL                                     \<QL           **TA102--S9**\   427 ± 40       \-             \-            \-           \-
                                                                                                 SRN = 485 ± 63                                                            

  (Flav+)        0.7500                  0.0140                                   0.0130         446 ± 10         507 ± 37       492 ± 61       490 ± 57      509 ± 32     

  0.5000         0.0093                  0.0087                                   475 ± 41       473 ± 39         471 ± 46       462 ± 73       458 ± 108                  

  0.1500         0.0028                  0.0026                                   490 ± 25       511 ± 49         478 ± 55       444 ± 63       502 ± 37                   
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------

AFB~1~: aflatoxin B~1~, AFB~2~: aflatoxin B~2~, AFM~1~: aflatoxin M~1;~ (Flav−): extract prepared from non toxigenic *A. flavus;* ^a^ mean revertant number ± standard deviation (SD); (Flav+): extract prepared from toxigenic *A. flavus* SRN: spontaneous revertant number (mean ± SD); \<QL: below to the limit of quantification; **In bold:** significant mutagenicity.

toxins-12-00458-t003_Table 3

###### 

Comparative mutagenicity of *Aspergillus flavus* (Flav^+/-^) extracts versus equivalent mix of mycotoxins, evaluated in *Salmonella* tester strains TA98, TA100 and TA102 with (+S9) metabolic activation.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Extract Type   Mycotoxins (µg/Plate)   Mutagenicity (+S9mix) (Rev/Plate ^a^)                                                                                             
  -------------- ----------------------- --------------------------------------- --------------- ----------------- -------------- -------------- ---------- -------------- ----
  **(Flav−)**    \<QL                    \<QL                                    \<QL            **TA98 + S9**\    28 ± 6         \-             \-         \-             \-
                                                                                                 SRN = 27 ± 10                                                             

  (Flav+)        0.0750                  0.0014                                  0.0013          **2154 ± 111**    **603 ± 83**   **413 ± 71**   20 ± 13    **200** ± 38   

  0.0250         0.0005                  0.0004                                  **1183 ± 61**   **248 ± 72**      **123 ± 14**   22 ± 8         50 ± 3                    

  0.0050         0.0001                  0.0001                                  **183 ± 26**    53 ± 8            47 ± 5         21 ± 11        63 ± 34                   

  (Flav−)        \<QL                    \<QL                                    \<QL            **TA100 + S9**\   105 ± 25       \-             \-         \-             \-
                                                                                                 SRN = 156 ± 43                                                            

  (Flav+)        0.0250                  0.0005                                  0.0004          **1905 ± 39**     **635 ± 56**   **783 ± 55**   153 ± 39   **306 ± 51**   

  0.0050         0.0001                  0.0001                                  **861 ± 84**    **253 ± 23**      **265 ± 12**   152 ± 14       136 ± 61                  

  0.0010         0.00002                 0.00002                                 227 ± 36        nd                nd             nd             185 ± 22                  

  (Flav−)        \<QL                    \<QL                                    \<QL            **TA102 + S9**\   409 ± 11       \-             \-         \-             \-
                                                                                                 SRN = 480 ± 65                                                            

  (Flav+)        0.5000                  0.0100                                  0.0080          **2222 ± 75**     539 ± 67       467 ± 78       481 ± 71   500 ± 26       

  0.3000         0.0030                  0.0048                                  **1699 ± 69**   529 ± 56          497 ± 40       475 ± 87       493 ± 23                  

  0.1500         0.0015                  0.0024                                  **806 ± 41**    578 ± 130         458 ± 29       488 ± 132      502 ± 67                  
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------

AFB~1~: aflatoxin B~1~, AFB~2~: aflatoxin B~2~, AFM~1~: aflatoxin M~1;~ (Flav−): extract prepared from non toxigenic *A. flavus;* ^a^ mean revertant number ± SD; (Flav+): extract prepared from toxigenic *A. flavus* SRN: spontaneous revertant number (mean ± SD); nd: not determined; \<QL: below to the limit of quantification; **In bold:** significant mutagenicity.

toxins-12-00458-t004_Table 4

###### 

Comparative mutagenicity of *Aspergillus parasiticus* (Para^+/−^) extracts versus equivalent mix of mycotoxins, evaluated in *Salmonella* tester strains TA98, TA100 and TA102 without (−S9) metabolic activation.

  -------------------------------------------------------------------------------------------------------------------
  Extract Type   Mycotoxins (µg/Plate)   Mutagenicity (−S9mix) (Rev/Plate ^a^)                                   
  -------------- ----------------------- --------------------------------------- ------------------ ------------ ----
  (Para−)        \<QL                    \<QL                                    **TA98 -- S9**\    27 ± 4       \-
                                                                                 SRN = 26 ± 10                   

  (Para+)        0.3000                  0.0050                                  **249 ± 17**       **76 ± 9**   

  0.1500         0.0025                  **213 ± 16**                            48 ± 10                         

  0.0500         0.0008                  **68 ± 20**                             41 ± 15                         

  (Para−)        \<QL                    \<QL                                    **TA100 -- S9**\   116 ± 7      \-
                                                                                 SRN = 146 ± 32                  

  (Para+)        0.3000                  0.0050                                  149 ± 19           184 ± 23     

  0.1500         0.0025                  167 ± 24                                205 ± 39                        

  0.0500         0.0008                  139 ± 4                                 140 ± 23                        

  (Para−)        \<QL                    \<QL                                    **TA102 -- S9**\   372 ± 22     \-
                                                                                 SRN = 485 ± 63                  

  (Para+)        0.3000                  0.0050                                  470 ± 22           509 ± 32     

  0.1500         0.0025                  475 ± 19                                458 ± 108                       

  0.0500         0.0008                  450 ± 26                                502 ± 37                        
  -------------------------------------------------------------------------------------------------------------------

(Para−): extract from non toxigenic *A. parasiticus*; (Para+): extract from toxigenic *A. parasiticus.*

toxins-12-00458-t005_Table 5

###### 

Comparative mutagenicity of *Aspergillus parasiticus* (Para^+/-^) extracts versus equivalent mix of mycotoxins, evaluated in *Salmonella* tester strains TA98, TA100 and TA102 with (+S9) metabolic activation.

  --------------------------------------------------------------------------------------------------------------------
  Extract Type   Mycotoxins (µg/Plate)   Mutagenicity (+S9mix) (Rev/Plate ^a^)                                    
  -------------- ----------------------- --------------------------------------- ----------------- -------------- ----
  (Para−)        \<QL                    \<QL                                    **TA98 + S9**\    23 ± 1         \-
                                                                                 SRN = 26 ± 10                    

  (Para+)        0.0050                  0.0001                                  **358 ± 36**      **125 ± 40**   

  0.0025         0.00005                 **141 ± 19**                            **57 ± 8**                       

  0.0010         0.00002                 **60 ± 1**                              29 ± 2                           

  (Para−)        \<QL                    \<QL                                    **TA100 + S9**\   126 ± 15       \-
                                                                                 SRN = 146 ± 32                   

  (Para+)        0.0050                  0.0001                                  **487 ± 27**      **232 ± 8**    

  0.0025         0.00005                 **247 ± 14**                            187 ± 8                          

  0.0010         0.00002                 160 ± 19                                142 ± 27                         

  (Para−)        \<QL                    \<QL                                    **TA102 + S9**\   446 ± 20       \-
                                                                                 SRN =4 80 ± 65                   

  (Para+)        0.3000                  0.0050                                  **751 ± 38**      **759 ± 36**   

  0.1500         0.0025                  664 ± 63                                579 ± 21                         

  0.0500         0.0008                  528 ± 4                                 489 ± 23                         
  --------------------------------------------------------------------------------------------------------------------

AFB~1~: aflatoxin B~1;~ AFB~2~: aflatoxin B~2~*;* (Para−): extract from non toxigenic *A. parasiticus*; (Para+): extract from toxigenic *A. parasiticus;* ^a^ mean revertant number; SRN: spontaneous revertant number (mean ± SD)*;* \<QL: below to the limit of quantification; **In bold**: significant mutagenicity.

toxins-12-00458-t006_Table 6

###### 

Comparative mutagenicity of toxigenic *Aspergillus fumigatus* (Fumi~Glio+/−~) extracts versus equivalent mix of pure mycotoxins, evaluated in *Salmonella* tester strains TA98, TA100 and TA102 without (−S9) metabolic activation.

  -------------------------------------------------------------------------------------------------------------------------------------------------
  Extract Type    \[Mycotoxins\] (µg/Plate)   Mutagenicity (−S9mix) (Rev/Plate ^a^)                                                            
  --------------- --------------------------- --------------------------------------- -------- ------------------ ----- ----- ----- ----- ---- ----
  (Fumi~Glio+~)   2.050                       0.040                                   0.010    **TA98 -- S9**\    22    ±     8     22    ±    7
                                                                                               SRN = 20 ± 3                                    

  0.410           0.008                       0.002                                   18       ±                  4     23    ±     2          

  (Fumi~Glio−~)   \<QL                        0.0130                                  0.0240   17                 ±     4     26    ±     7    

  \<QL            0.0026                      0.0048                                  19       ±                  1     24    ±     1          

  (Fumi~Glio+~)   2.050                       0.040                                   0.010    **TA100 -- S9**\   179   ±     44    141   ±    6
                                                                                               SRN=122 ± 22                                    

  0.410           0.008                       0.002                                   142      ±                  6     141   ±     7          

  (Fumi~Glio−~)   \<QL                        0.0130                                  0.0240   123                ±     9     119   ±     5    

  \<QL            0.0026                      0.0048                                  147      ±                  17    125   ±     25         

  (Fumi~Glio+~)   2.050                       0.040                                   0.010    **TA102 -- S9**\   494   ±     137   432   ±    48
                                                                                               SRN = 424 ± 13                                  

  0.410           0.008                       0.002                                   443      ±                  37    423   ±     45         

  (Fumi~Glio−~)   \<QL                        0.0130                                  0.0240   462                ±     23    403   ±     40   

  \<QL            0.0026                      0.0048                                  395      ±                  16    417   ±     15         
  -------------------------------------------------------------------------------------------------------------------------------------------------

FUM: fumagillin; GLIO: gliotoxin; VER: verruculogen; (Fumi~Glio+~): extract from *A. fumigatus* gliotoxin producer; (Fumi~Glio-~): extract from *A. fumigatus* gliotoxin not producer; ^a^ mean of the revertant number; SRN: spontaneous revertant number (mean ± SD); \<QL: below to the limit of quantification.

toxins-12-00458-t007_Table 7

###### 

Comparative mutagenicity of toxigenic *Aspergillus fumigatus* (Fumi~Glio+/-~) extracts versus equivalent mix of pure mycotoxins, evaluated in *Salmonella* tester strains TA98, TA100 and TA102 with metabolic activation (+S9).

  -------------------------------------------------------------------------------------------------------------------------------------------------
  Extract Type    \[Mycotoxins\] (µg/Plate)   Mutagenicity (Rev/Plate ^a^)                                                                     
  --------------- --------------------------- ------------------------------ -------- ----------------- --------- -------- -------- ----- ---- ----
  (Fumi~Glio+~)   2.050                       0.040                          0.010    **TA98 + S9**\    23        ±        1        22    ±    1
                                                                                      SRN = 19 ± 2                                             

  0.410           0.008                       0.002                          21       ±                 7         22       ±        2          

  (Fumi~Glio−~)   \<QL                        0.0130                         0.0240   18                ±         1        22       ±     1    

  \<QL            0.0026                      0.0048                         16       ±                 5         22       ±        2          

  (Fumi~Glio+~)   2,050                       0.040                          0.010    **TA100 + S9**\   103       ±        9        116   ±    18
                                                                                      SRN = 92 ± 23                                            

  0,410           0.008                       0.002                          73       ±                 5         122      ±        9          

  (Fumi~Glio−~)   \<QL                        0.0130                         0.0240   123               ±         21       117      ±     10   

  \<QL            0.0026                      0.0048                         95       ±                 16        130      ±        8          

  (Fumi~Glio+~)   2.050                       0.040                          0.010    **TA102 + S9**\   **539**   ±        **37**   373   ±    29
                                                                                      SRN = 388 ± 28                                           

  0.410           0.008                       0.002                          442      ±                 3         395      ±        24         

  (Fumi~Glio−~)   \<QL                        0.0130                         0.0240   **516**           ±         **34**   393      ±     11   

  \<QL            0.0026                      0.0048                         392      ±                 22        361      ±        54         
  -------------------------------------------------------------------------------------------------------------------------------------------------

FUM: fumagillin; GLIO: gliotoxin; VER: verruculogen; (Fumi~Glio+~): extract from *A. fumigatus* gliotoxin producer; (Fumi~Glio-~): extract from *A. fumigatus* gliotoxin not producer; ^a^ mean of the revertant number; SRN: spontaneous revertant number (mean ± SD); \<QL: below to the limit of quantification; **In** **bold**: samples displaying a significant mutagenicity.

toxins-12-00458-t008_Table 8

###### 

Mutagenicity of standard mycotoxins evaluated in *Salmonella* tester strains TA98, TA100 and TA102 without (−S9) or with (+S9) metabolic activation.

  -----------------------------------------------------------------------------------------------------------------------
  Mycotoxins                 Concentration (µg/Plate)   Mutagenicity (Revertants/Plate ^a^)                   
  ------------ ------------- -------------------------- ------------------------------------- --------------- -----------
  **None**     **−S9 +S9**   0\                         26 ± 10\                              146 ± 32\       485 ± 63\
                             0                          27 ± 10                               156 ± 43        480 ± 65

  **AFB~1~**   −S9           0.7500\                    **106 ± 40**\                         nd\             419 ± 86\
                             0.5000\                    nd\                                   **272 ± 95**\   458 ± 73\
                             0.3000\                    **53 ± 14**\                          201 ± 48\       nd\
                             0.1500                     29 ± 10                               154 ± 35        472 ± 91

  +S9          0,5000\       nd\                        nd\                                   473 ± 112\      
               0.3000\       nd\                        nd\                                   482 ± 133\      
               0.1500\       (T)\                       nd\                                   501 ± 104\      
               0.0750\       **1075 ± 112**\            (T)\                                  nd\             
               0.0250\       **275 ± 20**\              **1050 ± 161**\                       nd\             
               0.0050\       **88 ± 13**\               **279 ± 37**\                         nd\             
               0.0010        nd                         139 ± 38                              nd              

  **AFB~2~**   −S9           0.0140\                    20 ± 3\                               132 ± 7\        461 ± 14\
                             0.0050\                    20 ± 2\                               128 ± 6\        476 ± 27\
                             0.0010                     20 ± 2                                127 ± 17        449 ± 26

  +S9          0.0140\       28 ± 4\                    142 ± 12\                             416 ± 18\       
               0.0050\       25 ± 6\                    157 ± 9\                              418 ± 22\       
               0.0010        23 ± 1                     127 ± 2                               429 ± 17        

  **AFM~1~**   −S9           0.0130\                    18 ± 2\                               186 ± 2\        461 ± 14\
                             0.0020                     18 ± 3                                183 ± 10        463 ± 45

  +S9          0.0013\       23 ± 4\                    161 ± 11\                             475 ± 45\       
               0.0002        32 ± 2                     168 ± 6                               439 ± 27        

  **FUM**      −S9           0.0400\                    18 ± 2\                               140 ± 10\       468 ± 34\
                             0.0250\                    19 ± 2\                               149 ± 6\        451 ± 38\
                             0.0090                     22 ± 1                                148 ± 9         439 ± 6

  +S9          0.0400\       30 ± 11\                   133 ± 3\                              460 ± 7\        
               0.0250\       28 ± 2\                    123 ± 19\                             485 ± 30\       
               0.0090        31 ± 1                     127 ± 2                               493 ± 17        

  **GLIO**     −S9           2.0500\                    17 ± 4\                               130 ± 8\        457 ± 18\
                             0.4100                     20 ± 4                                131 ± 1         454 ± 20

  +S9          2.0500\       20 ± 1\                    148 ± 8\                              414 ± 17\       
               0.4100        22 ± 1                     148 ± 7                               388 ± 21        

  **VER**      −S9           0.0100\                    17 ± 2\                               141 ± 12\       442 ± 30\
                             0.0050                     19 ± 1                                145 ± 10        467 ± 19

  +S9          0.0100\       28 ± 3\                    157 ± 6\                              494 ± 8\        
               0.0050        28 ± 5                     158 ± 13                              349 ± 12        
  -----------------------------------------------------------------------------------------------------------------------

AFB~1~: aflatoxin B~1~, AFB~2~: aflatoxin B~2,~ AFM~1~: aflatoxin M~1~, FUM: fumagillin, GLIO: gliotoxin, VER: verruculogen; nd: not determined; (T) toxicity (lower density of the microscopic background lawn); ^a^ mean of the revertant number; In **bold**: samples displaying a significant mutagenicity.

toxins-12-00458-t009_Table 9

###### 

Comparative mutagenic potential of toxigenic *A. flavus* and *A. parasiticus* extracts versus pure AFB~1~ in *Salmonella* tester strains TA98, TA100 and TA102 without (−) or with (+) metabolic activation (S9).

  Strains     S9      Revertants/ng~AFB1~          
  ----------- ------- --------------------- ------ ------
  **TA98**    −       0.5                   1.4    0.18
  \+          47.3    71.6                  17.6   
  **TA100**   −       2.3                   \-     0.5
  \+          172.2   99                    55.8   
  **TA102**   −       \-                    \-     \-
  \+          5.7     4.4                   \-     

-: not mutagenic.
